A bone morphogenetic protein (BMP)-responsive element in the hepcidin promoter controls HFE2-mediated hepatic hepcidin expression and its response to IL-6 in cultured cells - PubMed (original) (raw)
A bone morphogenetic protein (BMP)-responsive element in the hepcidin promoter controls HFE2-mediated hepatic hepcidin expression and its response to IL-6 in cultured cells
Maria Vittoria Verga Falzacappa et al. J Mol Med (Berl). 2008 May.
Abstract
The precise regulation of the iron-regulatory hormone hepcidin is essential to maintain body iron homeostasis: Hepcidin deficiency induces iron overload, and hepcidin excess results in anaemia. Mutations in the gene HFE2 cause severe iron overload and are associated with low hepcidin expression. Recent data suggest that HFE2 is a bone morphogenetic protein (BMP) co-receptor, and that the decreased hepcidin mRNA expression because of HFE2 dysfunction is a result of impaired BMP signalling ability. In this study, we identify a critical BMP-responsive element (BMP-RE) at position -84/-79 of the hepcidin promoter. We show that this element mediates HFE2-dependent basal hepcidin mRNA expression under control conditions. Unexpectedly, the mutation of the same BMP-RE element also severely impairs hepcidin activation in response to IL-6. These data uncover a missing link in the HFE2-mediated control of hepcidin expression and suggest that the BMP-RE controls hepcidin promoter activity mediated by HFE2 and inflammatory stimuli.
Similar articles
- Bone morphogenetic protein (BMP)-responsive elements located in the proximal and distal hepcidin promoter are critical for its response to HJV/BMP/SMAD.
Casanovas G, Mleczko-Sanecka K, Altamura S, Hentze MW, Muckenthaler MU. Casanovas G, et al. J Mol Med (Berl). 2009 May;87(5):471-80. doi: 10.1007/s00109-009-0447-2. Epub 2009 Feb 20. J Mol Med (Berl). 2009. PMID: 19229506 - Bone morphogenetic protein signaling by hemojuvelin regulates hepcidin expression.
Babitt JL, Huang FW, Wrighting DM, Xia Y, Sidis Y, Samad TA, Campagna JA, Chung RT, Schneyer AL, Woolf CJ, Andrews NC, Lin HY. Babitt JL, et al. Nat Genet. 2006 May;38(5):531-9. doi: 10.1038/ng1777. Epub 2006 Apr 9. Nat Genet. 2006. PMID: 16604073 - Tumour necrosis factor alpha downregulates human hemojuvelin expression via a novel response element within its promoter.
Salama MF, Bayele HK, Srai SS. Salama MF, et al. J Biomed Sci. 2012 Sep 21;19(1):83. doi: 10.1186/1423-0127-19-83. J Biomed Sci. 2012. PMID: 22998440 Free PMC article. - Regulation of hepcidin and iron-overload disease.
Lee PL, Beutler E. Lee PL, et al. Annu Rev Pathol. 2009;4:489-515. doi: 10.1146/annurev.pathol.4.110807.092205. Annu Rev Pathol. 2009. PMID: 19400694 Review. - The iron driven pathway of hepcidin synthesis.
Deugnier Y. Deugnier Y. Gastroenterol Clin Biol. 2010 Aug-Sep;34(6-7):351-4. doi: 10.1016/j.gcb.2010.04.003. Epub 2010 May 27. Gastroenterol Clin Biol. 2010. PMID: 20537480 Review.
Cited by
- IL-6 Regulates Hepcidin Expression Via the BMP/SMAD Pathway by Altering BMP6, TMPRSS6 and TfR2 Expressions at Normal and Inflammatory Conditions in BV2 Microglia.
Varga E, Pap R, Jánosa G, Sipos K, Pandur E. Varga E, et al. Neurochem Res. 2021 May;46(5):1224-1238. doi: 10.1007/s11064-021-03322-0. Epub 2021 Apr 9. Neurochem Res. 2021. PMID: 33835366 Free PMC article. - The iron cycle in chronic kidney disease (CKD): from genetics and experimental models to CKD patients.
Zumbrennen-Bullough K, Babitt JL. Zumbrennen-Bullough K, et al. Nephrol Dial Transplant. 2014 Feb;29(2):263-73. doi: 10.1093/ndt/gft443. Epub 2013 Nov 13. Nephrol Dial Transplant. 2014. PMID: 24235084 Free PMC article. Review. - Hepcidin modulation in human diseases: from research to clinic.
Piperno A, Mariani R, Trombini P, Girelli D. Piperno A, et al. World J Gastroenterol. 2009 Feb 7;15(5):538-51. doi: 10.3748/wjg.15.538. World J Gastroenterol. 2009. PMID: 19195055 Free PMC article. Review. - Iron and inflammation: cross-talk between pathways regulating hepcidin.
Fleming RE. Fleming RE. J Mol Med (Berl). 2008 May;86(5):491-4. doi: 10.1007/s00109-008-0349-8. J Mol Med (Berl). 2008. PMID: 18425494 No abstract available. - CD81 promotes both the degradation of transferrin receptor 2 (TfR2) and the Tfr2-mediated maintenance of hepcidin expression.
Chen J, Enns CA. Chen J, et al. J Biol Chem. 2015 Mar 20;290(12):7841-50. doi: 10.1074/jbc.M114.632778. Epub 2015 Jan 29. J Biol Chem. 2015. PMID: 25635054 Free PMC article.
References
- Br J Haematol. 2004 Aug;126(3):434-6 - PubMed
- Genes Dev. 2005 Dec 1;19(23):2783-810 - PubMed
- Nat Genet. 2003 Jan;33(1):21-2 - PubMed
- J Clin Invest. 2005 Aug;115(8):2187-91 - PubMed
- Mol Biol Cell. 2000 Feb;11(2):555-65 - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources